| Schedule of Condensed Statements of Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
2024 |
|
2023 |
|
2022 |
| Stock compensation expense |
$ |
14,043 |
|
|
$ |
16,031 |
|
|
$ |
20,632 |
|
| Equity in net (income) from subsidiaries |
(7,391) |
|
|
(87,185) |
|
|
(94,329) |
|
| Net (loss) income |
(6,652) |
|
|
71,154 |
|
|
73,697 |
|
| Other comprehensive income (loss), net of tax: |
|
|
|
|
|
| Pension and postretirement benefits |
855 |
|
|
1,120 |
|
|
(2,676) |
|
| Net (loss) gain from hedging activities |
(2,644) |
|
|
(12,126) |
|
|
24,382 |
|
| Foreign currency translation |
(4,660) |
|
|
4,056 |
|
|
(9,922) |
|
| Total other comprehensive (loss) income |
(6,449) |
|
|
(6,950) |
|
|
11,784 |
|
| Comprehensive (loss) income |
$ |
(13,101) |
|
|
$ |
64,204 |
|
|
$ |
85,481 |
|
|
|
|
|
|
|
|
| Schedule of Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2024 |
|
2023 |
| ASSETS |
|
|
|
|
|
|
|
| Investment in subsidiaries |
$ |
700,460 |
|
|
$ |
705,464 |
|
| Total assets |
$ |
700,460 |
|
|
$ |
705,464 |
|
| LIABILITIES |
|
|
|
|
|
|
|
| Total liabilities |
$ |
— |
|
|
$ |
— |
|
| STOCKHOLDERS' EQUITY |
|
|
|
Common stock (0.01 par); authorized shares 450,000,000; issued shares 140,872,846 and 140,744,045 on December 31, 2024 and 2023, respectively; outstanding shares 116,534,803 and 116,116,895 on December 31, 2024 and 2023, respectively |
1,409 |
|
|
1,407 |
|
Preferred stock (0.01 par); authorized shares 50,000,000; no shares issued or outstanding on December 31, 2024 and 2023, respectively |
— |
|
|
— |
|
| Additional paid-in capital |
1,106,792 |
|
|
1,102,581 |
|
| Accumulated deficit |
(177,508) |
|
|
(170,856) |
|
Treasury stock, at cost; shares 24,338,043 and 24,627,150 on December 31, 2024 and 2023, respectively |
(222,826) |
|
|
(226,710) |
|
| Accumulated other comprehensive loss |
(7,407) |
|
|
(958) |
|
| Total equity |
700,460 |
|
|
705,464 |
|
| Total liabilities and equity |
$ |
700,460 |
|
|
$ |
705,464 |
|
|
|
|
|
|
| Schedule of Condensed Statements of Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
|
2024 |
|
2023 |
|
2022 |
| Cash flows from operating activities: |
|
|
|
|
|
| Net (loss) income |
$ |
(6,652) |
|
|
$ |
71,154 |
|
|
$ |
73,697 |
|
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
|
|
|
| Equity in net (income) from subsidiaries |
(7,391) |
|
|
(87,185) |
|
|
(94,329) |
|
| Stock compensation expense |
14,043 |
|
|
16,031 |
|
|
20,632 |
|
| Net cash provided by operating activities |
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Effect of exchange rate changes on cash and cash equivalents |
— |
|
|
— |
|
|
— |
|
| Net change in cash and cash equivalents |
— |
|
|
— |
|
|
— |
|
| Cash and cash equivalents at beginning of period |
— |
|
|
— |
|
|
— |
|
| Cash and cash equivalents at end of period |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|